U.S. Physical [USPH] vs Select Medical [SEM] Detailed Stock Comparison
U.S. Physical
NYSE
Loading...
Select Medical
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: U.S. Physical wins in 10 metrics, Select Medical wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | U.S. Physical | Select Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 38.84 | 23.21 | Select Medical |
| Price-to-Book Ratio | 2.70 | 1.07 | Select Medical |
| Debt-to-Equity Ratio | 39.89 | 136.22 | U.S. Physical |
| PEG Ratio | 1.66 | 6.37 | U.S. Physical |
| EV/EBITDA | 19.52 | 12.71 | Select Medical |
| Profit Margin (TTM) | 5.28% | 3.33% | U.S. Physical |
| Operating Margin (TTM) | 12.40% | 8.33% | U.S. Physical |
| EBITDA Margin (TTM) | 12.40% | 8.33% | U.S. Physical |
| Return on Equity | 7.45% | 7.72% | Select Medical |
| Return on Assets (TTM) | 4.24% | 2.42% | U.S. Physical |
| Free Cash Flow (TTM) | $65.75M | $295.69M | Select Medical |
| Dividend Yield | 1.80% | 65.77% | Select Medical |
| 1-Year Return | 11.51% | -28.36% | U.S. Physical |
| Price-to-Sales Ratio (TTM) | 1.87 | 0.35 | Select Medical |
| Enterprise Value | $1.89B | $4.91B | Select Medical |
| EV/Revenue Ratio | 2.61 | 0.94 | Select Medical |
| Gross Profit Margin (TTM) | 21.09% | 13.34% | U.S. Physical |
| Revenue per Share (TTM) | $48 | $42 | U.S. Physical |
| Earnings per Share (Diluted) | $2.29 | $0.62 | U.S. Physical |
| Beta (Stock Volatility) | 1.48 | 1.20 | Select Medical |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
U.S. Physical vs Select Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| U.S. Physical | 0.66% | 7.22% | 5.58% | 12.82% | 37.57% | 1.88% |
| Select Medical | 0.62% | 4.08% | -1.81% | -12.21% | -16.92% | -30.76% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| U.S. Physical | 11.51% | 15.64% | 4.12% | 93.70% | 396.29% | 413.65% |
| Select Medical | -28.36% | 10.07% | 5.77% | 121.64% | 218.09% | 139.15% |
News Based Sentiment: U.S. Physical vs Select Medical
U.S. Physical
News based Sentiment: POSITIVE
U.S. Physical Therapy delivered a strong Q2 2025, exceeding revenue and EPS estimates, and continued its growth strategy through acquisitions. Increased institutional investment further supports a positive outlook, despite some insider selling. These developments collectively strengthen the investment case.
Select Medical
News based Sentiment: MIXED
October brought a mix of developments for Select Medical, with positive analyst ratings and growth in the rehabilitation segment offset by challenges in critical illness recovery and a decrease in cash. The upcoming Q3 earnings release will be a key event for investors to assess the company's overall performance and future prospects.
Performance & Financial Health Analysis: U.S. Physical vs Select Medical
| Metric | USPH | SEM |
|---|---|---|
| Market Information | ||
| Market Cap | $1.35B | $1.85B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 174,136 | 1,083,480 |
| 90 Day Avg. Volume | 141,942 | 1,361,833 |
| Last Close | $89.53 | $13.01 |
| 52 Week Range | $62.77 - $101.20 | $11.65 - $22.08 |
| % from 52W High | -11.53% | -41.08% |
| All-Time High | $148.48 (Nov 04, 2019) | $23.49 (Jun 21, 2021) |
| % from All-Time High | -39.70% | -44.61% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.18% | 0.02% |
| Quarterly Earnings Growth | 0.65% | -0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.03% |
| Operating Margin (TTM) | 0.12% | 0.08% |
| Return on Equity (TTM) | 0.07% | 0.08% |
| Debt to Equity (MRQ) | 39.89 | 136.22 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $32.94 | $13.40 |
| Cash per Share (MRQ) | $2.33 | $0.41 |
| Operating Cash Flow (TTM) | $71.72M | $581.10M |
| Levered Free Cash Flow (TTM) | $48.72M | $218.65M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.80% | 65.77% |
| Last 12-Month Dividend | $1.33 | $9.82 |
Valuation & Enterprise Metrics Analysis: U.S. Physical vs Select Medical
| Metric | USPH | SEM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 38.84 | 23.21 |
| Forward P/E | 30.67 | 6.37 |
| PEG Ratio | 1.66 | 6.37 |
| Price to Sales (TTM) | 1.87 | 0.35 |
| Price to Book (MRQ) | 2.70 | 1.07 |
| Market Capitalization | ||
| Market Capitalization | $1.35B | $1.85B |
| Enterprise Value | $1.89B | $4.91B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.61 | 0.94 |
| Enterprise to EBITDA | 19.52 | 12.71 |
| Risk & Other Metrics | ||
| Beta | 1.48 | 1.20 |
| Book Value per Share (MRQ) | $32.94 | $13.40 |
Financial Statements Comparison: U.S. Physical vs Select Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | USPH | SEM |
|---|---|---|
| Revenue/Sales | $183.79M | $1.35B |
| Cost of Goods Sold | $152.72M | $1.17B |
| Gross Profit | $31.07M | $180.56M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $14.82M | $112.75M |
| EBITDA | $21.18M | $160.07M |
| Pre-Tax Income | $17.33M | $96.19M |
| Income Tax | $3.86M | $21.45M |
| Net Income (Profit) | $13.47M | $74.73M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | USPH | SEM |
|---|---|---|
| Cash & Equivalents | $39.18M | $59.69M |
| Total Current Assets | $145.35M | $1.02B |
| Total Current Liabilities | $123.80M | $977.65M |
| Long-Term Debt | $257.93M | $2.48B |
| Total Shareholders Equity | $759.01M | $2.00B |
| Retained Earnings | $234.16M | $770.15M |
| Property, Plant & Equipment | $133.20M | $908.10M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | USPH | SEM |
|---|---|---|
| Operating Cash Flow | $7.98M | $129.35M |
| Capital Expenditures | $-2.58M | $-63.43M |
| Free Cash Flow | $-7.25M | $62.00M |
| Debt Repayment | $-4.22M | $-1.82B |
| Common Stock Repurchase | N/A | $-19.98M |
Short Interest & Institutional Ownership Analysis
| Metric | USPH | SEM |
|---|---|---|
| Shares Short | 716,257 | 3.83M |
| Short Ratio | 5.56 | 3.80 |
| Short % of Float | 0.06% | 0.07% |
| Average Daily Volume (10 Day) | 174,136 | 1,083,480 |
| Average Daily Volume (90 Day) | 141,942 | 1,361,833 |
| Shares Outstanding | 15.09M | 128.96M |
| Float Shares | 14.89M | 109.67M |
| % Held by Insiders | 0.02% | 0.14% |
| % Held by Institutions | 1.06% | 0.85% |
Dividend Analysis & Yield Comparison: U.S. Physical vs Select Medical
| Metric | USPH | SEM |
|---|---|---|
| Last 12-Month Dividend | $1.33 | $9.82 |
| Last 12-Month Dividend Yield | 1.80% | 65.77% |
| 3-Year Avg Annual Dividend | $1.44 | $3.44 |
| 3-Year Avg Dividend Yield | 0.47% | 4.54% |
| 3-Year Total Dividends | $4.32 | $10.31 |
| Ex-Dividend Date | Mar 14, 2025 | Mar 03, 2025 |